Zymeworks Common Stock Stock Performance
| ZYME Stock | USD 14.50 0.41 2.91% |
On a scale of 0 to 100, Zymeworks Common holds a performance score of 10. The firm maintains a market beta of 0.85, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Zymeworks Common's returns are expected to increase less than the market. However, during the bear market, the loss of holding Zymeworks Common is expected to be smaller as well. Please check Zymeworks Common's value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Zymeworks Common's historical returns will revert.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Zymeworks Common Stock are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating primary indicators, Zymeworks Common exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 2.91 | Five Day Return 0.28 | Year To Date Return 39.69 | Ten Year Return 11.54 | All Time Return 11.54 |
1 | GSK Q3 Earnings Surpass Estimates | 10/30/2024 |
2 | Zymeworks Inc. Reports Q3 Loss, Lags Revenue Estimates | 10/31/2024 |
3 | Zymeworks Inc Q3 2024 Earnings Call Highlights Strategic Advances Amid Financial Challenges | 11/01/2024 |
4 | Leerink lifts Zymeworks stock target on pipeline progress | 11/07/2024 |
5 | Zymeworks Hits New 12-Month High Should You Buy | 11/14/2024 |
6 | Acquisition by Kenneth Galbraith of 215000 shares of Zymeworks Common at 8.0 subject to Rule 16b-3 | 11/20/2024 |
7 | FDA Grants U.S. Approval of Ziihera for the | 11/21/2024 |
8 | Personalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 SkyQuest Technology | 11/27/2024 |
| Begin Period Cash Flow | 400.9 M |
Zymeworks |
Zymeworks Common Relative Risk vs. Return Landscape
If you would invest 1,159 in Zymeworks Common Stock on September 4, 2024 and sell it today you would earn a total of 291.00 from holding Zymeworks Common Stock or generate 25.11% return on investment over 90 days. Zymeworks Common Stock is currently generating 0.3976% in daily expected returns and assumes 2.9278% risk (volatility on return distribution) over the 90 days horizon. In different words, 26% of stocks are less volatile than Zymeworks, and 93% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Zymeworks Common Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zymeworks Common's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Zymeworks Common Stock, and traders can use it to determine the average amount a Zymeworks Common's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1358
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ZYME | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.93 actual daily | 26 74% of assets are more volatile |
Expected Return
| 0.4 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average Zymeworks Common is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zymeworks Common by adding it to a well-diversified portfolio.
Zymeworks Common Fundamentals Growth
Zymeworks Stock prices reflect investors' perceptions of the future prospects and financial health of Zymeworks Common, and Zymeworks Common fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Zymeworks Stock performance.
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.15 | ||||
| Profit Margin | (1.83) % | ||||
| Operating Margin | (2.14) % | ||||
| Current Valuation | 721.77 M | ||||
| Shares Outstanding | 68.88 M | ||||
| Price To Earning | (2.36) X | ||||
| Price To Book | 2.72 X | ||||
| Price To Sales | 16.06 X | ||||
| Revenue | 76.01 M | ||||
| Gross Profit | 203.78 M | ||||
| EBITDA | (129.96 M) | ||||
| Net Income | (118.67 M) | ||||
| Cash And Equivalents | 241.83 M | ||||
| Cash Per Share | 4.18 X | ||||
| Total Debt | 26.72 M | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 3.29 X | ||||
| Book Value Per Share | 5.27 X | ||||
| Cash Flow From Operations | (118.3 M) | ||||
| Earnings Per Share | (1.49) X | ||||
| Market Capitalization | 998.72 M | ||||
| Total Asset | 580.88 M | ||||
| Retained Earnings | (677.44 M) | ||||
| Working Capital | 357.16 M | ||||
About Zymeworks Common Performance
By analyzing Zymeworks Common's fundamental ratios, stakeholders can gain valuable insights into Zymeworks Common's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Zymeworks Common has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Zymeworks Common has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.22) | (0.23) | |
| Return On Capital Employed | (0.26) | (0.28) | |
| Return On Assets | (0.20) | (0.21) | |
| Return On Equity | (0.26) | (0.27) |
Things to note about Zymeworks Common Stock performance evaluation
Checking the ongoing alerts about Zymeworks Common for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Zymeworks Common Stock help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 76.01 M. Net Loss for the year was (118.67 M) with profit before overhead, payroll, taxes, and interest of 203.78 M. | |
| Zymeworks Common Stock currently holds about 241.83 M in cash with (118.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.18. | |
| Zymeworks Common has a poor financial position based on the latest SEC disclosures | |
| Over 99.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Personalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 SkyQuest Technology |
- Analyzing Zymeworks Common's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Zymeworks Common's stock is overvalued or undervalued compared to its peers.
- Examining Zymeworks Common's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Zymeworks Common's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Zymeworks Common's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Zymeworks Common's stock. These opinions can provide insight into Zymeworks Common's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Zymeworks Stock analysis
When running Zymeworks Common's price analysis, check to measure Zymeworks Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zymeworks Common is operating at the current time. Most of Zymeworks Common's value examination focuses on studying past and present price action to predict the probability of Zymeworks Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zymeworks Common's price. Additionally, you may evaluate how the addition of Zymeworks Common to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |